Investing.com - Financial Markets Worldwide

Sinco Pharmaceuticals Holdings Ltd (6833)

Hong Kong
Currency in HKD
0.210
0.000(0.00%)
Closed·
6833 Scorecard
Full Analysis
Trading at a low Price / Book multiple
6833 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.2090.210
52 wk Range
0.1500.320
Key Statistics
Edit
Bid/Ask
0.21 / 0.23
Prev. Close
0.21
Open
0.209
Day's Range
0.209-0.21
52 wk Range
0.15-0.32
Volume
52K
Average Volume (3m)
222.58K
1-Year Change
-11.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6833 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Quickly burning through cash
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Sinco Pharmaceuticals Holdings Ltd Company Profile

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, including infections of the lower respiratory tract, such as pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. The company also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases comprising alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, an oral cholic acid drug that is used for the treatment of gallstone diseases or cholelithiasis; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, it is involved in the research, development, and sale of pharmaceutical products; provision of warehouse facilities for pharmaceutical products; research and manufacturing of aesthetic medicine; international trade activities; consultation services for medical and biological technology; market promotion; and medical beauty services. The company was founded in 2011 and is headquartered in Chengdu, the People’s Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
291
Market
Hong Kong

Compare 6833 to Peers and Sector

Metrics to compare
6833
Peers
Sector
Relationship
P/E Ratio
9.3x15.1x−0.5x
PEG Ratio
-−0.380.00
Price/Book
0.6x0.9x2.6x
Price / LTM Sales
0.1x0.4x3.3x
Upside (Analyst Target)
-16.7%40.3%
Fair Value Upside
Unlock13.7%4.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.02%
Dividend Yield
0.95%
Industry Median 2.38%
Annualised payout
0.00
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
0.01 / --
Revenue / Forecast
1.29B / --
EPS Revisions
a
a
Unlock
Last 90 days

6833 Income Statement

FAQ

What Stock Exchange Does Sinco Pharmas Trade On?

Sinco Pharmas is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Sinco Pharmas?

The stock symbol for Sinco Pharmas is "6833."

What Is the Sinco Pharmas Market Cap?

As of today, Sinco Pharmas market cap is 426.91M.

What Is Sinco Pharmas's Earnings Per Share (TTM)?

The Sinco Pharmas EPS (TTM) is 0.02.

From a Technical Analysis Perspective, Is 6833 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Sinco Pharmas Stock Split?

Sinco Pharmas has split 0 times.

How Many Employees Does Sinco Pharmas Have?

Sinco Pharmas has 291 employees.

What is the current trading status of Sinco Pharmas (6833)?

As of 14 Aug 2025, Sinco Pharmas (6833) is trading at a price of 0.21, with a previous close of 0.21. The stock has fluctuated within a day range of 0.21 to 0.21, while its 52-week range spans from 0.15 to 0.32.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.